| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $3.79 ▼ -2.57% | Yesterday | $3.89 • 0.00% | Tomorrow's SAB Biotherapeutics Inc. Common Stock (SABS) setup is anchored to $3.89 and targets $3.79 (-2.57%). The near-term read is downside; watch $4.08 / $3.70 because daily realized volatility is about 5.32%. |
Tomorrow's SAB Biotherapeutics Inc. Common Stock (SABS) setup is anchored to $3.89 and targets $3.79 (-2.57%). The near-term read is downside; watch $4.08 / $3.70 because daily realized volatility is about 5.32%. | ||||
| Week | $3.72 ▼ -4.37% | Last Week | $3.89 • 0.00% | The 7-day SAB Biotherapeutics Inc. Common Stock model moves from $3.89 to $3.72 (-4.37%). It gives downside momentum context for this stock, so breaks around $4.08 / $3.70 matter more than a single tick. |
The 7-day SAB Biotherapeutics Inc. Common Stock model moves from $3.89 to $3.72 (-4.37%). It gives downside momentum context for this stock, so breaks around $4.08 / $3.70 matter more than a single tick. | ||||
| Month | $3.60 ▼ -7.46% | Last Month | $3.89 • 0.00% | The 1-month SAB Biotherapeutics Inc. Common Stock target is $3.60 (-7.46%), compared with the live reference near $3.89. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month SAB Biotherapeutics Inc. Common Stock target is $3.60 (-7.46%), compared with the live reference near $3.89. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $3.43 ▼ -11.83% | Last Year | $3.89 • 0.00% | The 1-year SAB Biotherapeutics Inc. Common Stock scenario points to $3.43 (-11.83%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year SAB Biotherapeutics Inc. Common Stock scenario points to $3.43 (-11.83%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $3.03 ▼ -22.11% | 5 Years Ago | $3.89 • 0.00% | The 5-year SAB Biotherapeutics Inc. Common Stock view is $3.03 (-22.11%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year SAB Biotherapeutics Inc. Common Stock view is $3.03 (-22.11%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 49.6 | Neutral |
| MACD | -0.06 | Bearish |
| SMA 50 | $3.80 | Mid |
| SMA 200 | $3.83 | Mid |
| EMA 20 | $3.79 | Mid |
| Opening Price | $3.89 | Start Date | 2021-05-15 |
| Day Range | $3.76 – $4.02 | Market Cap | $194.12M |
| Monthly Range | $3.37 – $4.14 | 24h Volume | n/a |
| 90D Range | $3.29 – $4.22 | Circulating | n/a |
| 52W Range | $3.05 – $4.32 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.